Product image of Nimesil (Nimesulide) supplied by GNH India

Nimesil

Active Ingredient:
Nimesulide
Origin:
EU

Nimesil (Nimesulide)

Nimesulide, the active ingredient in Nimesil, is a NSAID presented as a 100 mg oral suspension for oral use. It provides symptomatic relief of pain, fever and inflammation and is prescribed for adults with conditions such as osteoarthritis and dysmenorrhea. It is indicated for short‑term management of acute musculoskeletal pain and menstrual cramps.

GNH India supplies Nimesil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice and delivers to a global network of healthcare facilities.

Manufacturer / TM Owner

Laboratori Guidotti S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nimesil (nimesulide) acts on inflammatory pathways to alleviate several common conditions.

  • Pain: provides symptomatic relief of mild to moderate pain.
  • Fever: reduces elevated body temperature associated with acute febrile states.
  • Inflammation: decreases inflammatory response in acute musculoskeletal conditions.
  • Osteoarthritis: alleviates joint pain and improves functional mobility in osteoarthritis.
  • Dysmenorrhea: eases menstrual pain and associated discomfort.

How It Works

  • Nimesulide selectively inhibits the cyclo‑oxygenase‑2 (COX‑2) enzyme, leading to reduced synthesis of prostaglandins that mediate inflammation, pain and fever. By lowering prostaglandin levels, it diminishes the inflammatory cascade and produces analgesic and antipyretic effects without markedly affecting COX‑1 activity.

Side Effects

Nimesil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
  • Headache: mild to moderate intensity.
  • Dizziness: transient sensation of light‑headedness.
  • Skin rash: mild erythematous eruptions.

Serious or Rare Side Effects

  • Hepatotoxicity: signs of liver injury such as jaundice or elevated enzymes.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Renal impairment: reduced kidney function or acute renal failure.
  • Gastrointestinal ulcer or bleeding: serious bleeding events in the stomach or intestines.

Precautions & Warnings

Before prescribing Nimesil, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

  • Renal function: assess baseline kidney status and monitor during therapy.
  • Hepatic function: check liver enzymes before initiation and periodically thereafter.
  • Gastrointestinal risk: use with caution in patients with a history of ulcer disease or bleeding.
  • Cardiovascular risk: avoid in uncontrolled hypertension or heart failure.
  • Pregnancy and lactation: safety not established; avoid unless clearly needed.
  • Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture.

Avoid Interactions

Nimesil can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased bleeding risk.
  • Other NSAIDs or aspirin: heightened gastrointestinal toxicity.
  • Corticosteroids: additive risk of ulceration and bleeding.
  • Lithium: possible increase in lithium serum levels.
  • Methotrexate: enhanced toxicity, especially at high doses.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: may reduce renal function.
  • Diuretics: potential for reduced renal perfusion.
  • Antihypertensives: possible attenuation of blood‑pressure control.
  • SSRIs: modest increase in bleeding tendency.
  • Oral hypoglycemics: may affect glucose control.

Frequently Asked Questions

Nimesil contains nimesulide and is indicated for short‑term treatment of mild‑to‑moderate pain, fever and inflammatory conditions such as osteoarthritis and dysmenorrhea. It provides symptomatic relief under the direction of a healthcare professional.

Nimesulide selectively blocks the cyclo‑oxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins that drive inflammation, pain and fever. This targeted inhibition lowers inflammatory mediators while sparing COX‑1 activity.

The prescribed dose of Nimesil is determined by the treating clinician based on the patient’s age, weight, clinical condition and organ function. The prescriber will specify the exact volume of the oral suspension and the dosing interval.

The safety of nimesulide during pregnancy and lactation has not been established. It is generally avoided in pregnant or nursing women unless the potential benefit outweighs the potential risk, and only under medical supervision.

To request Nimesil, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nimesulide is a selective COX‑2 inhibitor, which may lower the risk of gastrointestinal irritation compared with non‑selective NSAIDs such as ibuprofen or diclofenac. However, it carries its own safety considerations, including potential liver toxicity, and should be chosen based on individual patient risk factors and physician judgment.

Nimesil oral suspension should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the bottle is tightly closed when not in use.

Nimesil is taken orally as a suspension. The prescribed dose is measured with a calibrated dosing device such as a syringe or measuring cup and ingested with or without food as directed by the healthcare provider.

Serious adverse reactions to nimesulide can include liver injury, severe skin reactions like Stevens‑Johnson syndrome, gastrointestinal bleeding or ulceration, and renal impairment. Patients should be monitored for signs such as jaundice, rash, abdominal pain or reduced urine output and seek medical attention promptly if they occur.

Nimesil is contraindicated in individuals with known hypersensitivity to nimesulide or other NSAIDs, those with active peptic ulcer disease, severe hepatic or renal impairment, and patients with established cardiovascular disease where NSAIDs are contraindicated. It should also be avoided in pregnant women unless clearly indicated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nimesulide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT